Surgical Emergency | Pain Out of Proportion | Early Debridement Saves Lives
- Pain out of proportion to clinical findings is the classic early sign - do not dismiss this
- Hard signs: Crepitus, skin necrosis, bullae, 'dishwater' pus - immediate surgery
- Soft signs: Disproportionate pain, rapidly spreading erythema, systemic toxicity - high suspicion
- LRINEC score ≥6: Intermediate risk; ≥8 strongly predictive - do not rely on score alone
- Finger test: Incision, lack of bleeding, 'dishwater' pus, fascial necrosis confirms diagnosis
- Time is tissue: Delay to debridement is the key modifiable driver of mortality (non-survivors waited ~90h vs ~25h for survivors)
- “Pain out of proportion + systemic toxicity = necrotizing fasciitis until proven otherwise
- “Type I (polymicrobial): Diabetics, post-op, perineum (Fournier's) - mixed organisms
- “Type II (monomicrobial): GAS in healthy adults - TOXIC SHOCK SYNDROME
- “Clindamycin is essential - inhibits toxin production (Eagle effect)
- “Surgery is diagnosis AND treatment - CT/MRI delays cost lives
The earliest and most important sign. Patient reports severe pain but examination findings are minimal. Pain often extends beyond visible erythema. Do NOT dismiss this symptom - it reflects deep tissue ischemia from fascial necrosis and vessel thrombosis.
Hard signs (100% sensitivity): Crepitus, skin necrosis, bullae (hemorrhagic or serous), 'dishwater' gray discharge, visible fascial necrosis. Soft signs: Disproportionate pain, rapidly spreading cellulitis, systemic toxicity, failure to respond to antibiotics.
Laboratory Risk Indicator for NECrotizing fasciitis. Score ≥6 = intermediate risk; ≥8 = high risk. Components: CRP, WCC, Hb, Na, Creatinine, Glucose. CRITICAL: A low LRINEC does NOT exclude NF - clinical suspicion trumps scoring systems.
Delay to debridement is the strongest modifiable predictor of death - in McHenry's series non-survivors waited a mean 90 hours versus 25 hours for survivors. Delay beyond 12 hours markedly increases the number of debridements, septic shock and renal failure (Kobayashi). Do NOT delay surgery for CT/MRI - the operating theatre is both diagnostic and therapeutic.
- Type I (Polymicrobial)
- Mixed aerobic + anaerobic (Streptococcus, Enterococcus, E. coli, Bacteroides, Peptostreptococcus)
- Type II (Monomicrobial)
- Single organism: GAS (Strep pyogenes), S. aureus (MRSA), less commonly Clostridium
- Type I (Polymicrobial)
- Elderly, diabetics, immunocompromised, post-surgical, perineal (Fournier's)
- Type II (Monomicrobial)
- Previously healthy adults, children, minor trauma or NSAID use
- Type I (Polymicrobial)
- Surgery, perianal abscess, decubitus ulcer, diabetic foot
- Type II (Monomicrobial)
- Minor skin break, insect bite, blunt trauma, varicella (children)
- Type I (Polymicrobial)
- Common (anaerobic organisms)
- Type II (Monomicrobial)
- Less common (unless clostridial superinfection)
- Type I (Polymicrobial)
- Less common
- Type II (Monomicrobial)
- Very common with GAS - high mortality
- Type I (Polymicrobial)
- Broad-spectrum: Piperacillin-tazobactam + Clindamycin ± Vancomycin
- Type II (Monomicrobial)
- Penicillin + Clindamycin (GAS); Vancomycin + Clindamycin (MRSA)
- Type I (Polymicrobial)
- 15-30%
- Type II (Monomicrobial)
- 30-50% (higher with TSS)
CWHSCGLRINEC Score Components
Hook:CRP-WCC-Haemoglobin-Sodium-Creatinine-Glucose. Score 6+ = intermediate risk, 8+ = high risk. But clinical judgement trumps score!
CNBDHard Signs of Necrotizing Fasciitis
Hook:CNBD: Crepitus, Necrosis, Bullae, Dishwater pus = IMMEDIATE surgery. Any hard sign = theatre NOW!
DIABETICCauses/Risk Factors
Hook:DIABETIC: Most NF occurs in diabetics and immunocompromised. But Type II GAS can occur in healthy adults!
Overview and Epidemiology
Necrotizing fasciitis (NF) is a rapidly progressive, life-threatening soft tissue infection characterized by necrosis of fascia and subcutaneous tissue with relative sparing of overlying skin (initially) and underlying muscle. It represents a surgical emergency where early recognition and aggressive debridement are the only interventions that improve survival. [1]
Necrotizing fasciitis is a necrotizing soft tissue infection (NSTI) involving the fascial planes, spreading along the relatively avascular fascia with thrombosis of perforating vessels leading to secondary skin necrosis. Unlike cellulitis, the infection travels in the deep fascial planes, making surface examination misleadingly benign. [2]
- Incidence: 0.4-0.9 per 100,000 population per year [3]
- Increasing incidence: 2-4 fold increase over past 20 years
- Mortality: 20-40% overall; up to 70-80% with delayed treatment or toxic shock syndrome
- Male:Female ratio: 2-3:1
- Age: Bimodal - peaks in neonates and adults over 50 years
- Fournier's gangrene (perineal NF): 40% mortality
- First described by Confederate surgeon Joseph Jones in 1871 during American Civil War
- Term "necrotizing fasciitis" coined by Wilson in 1952
- Previously known as "hospital gangrene," "streptococcal gangrene"
- Remains associated with military trauma, natural disasters, and IV drug use epidemics
Necrotizing fasciitis is an orthopaedic oral examination favourite because it tests:
- Recognition of a surgical emergency from clinical signs
- Understanding of soft tissue anatomy and fascial planes
- Knowledge of microbiology and antibiotic selection
- Surgical decision-making (when to operate, when to return)
- Ethical aspects of life-threatening disease and limb sacrifice
The examiner wants to hear: "Pain out of proportion = NF until proven otherwise. When in doubt, cut it out."
Pathophysiology
Mechanism of Tissue Destruction:
Necrotizing fasciitis spreads along fascial planes because:
- Fascia is relatively avascular - fewer immune cells reach infection
- Bacteria produce enzymes (hyaluronidase, lipases, collagenases) that digest connective tissue
- Thrombosis of perforating vessels leads to skin ischemia (explains pain out of proportion)
- Toxin production causes systemic toxicity and shock
- Synergistic infection with aerobic and anaerobic organisms
- Aerobes consume oxygen, creating hypoxic environment
- Anaerobes thrive in hypoxia, produce gas (crepitus)
- Typically occurs in compromised tissue (diabetes, PVD, post-surgical)
- Enzymes from multiple organisms accelerate tissue destruction
- Group A Streptococcus produces multiple virulence factors:
- Streptolysin O and S: Pore-forming toxins causing cell lysis
- Streptococcal pyrogenic exotoxins (SPE-A, B, C): Superantigens causing massive cytokine release
- M-protein: Antiphagocytic, promotes adherence
- Streptokinase: Activates plasminogen, promotes spread
- Streptococcal Toxic Shock Syndrome (STSS): Superantigen activates 20-30% of T-cells (vs 0.01% in normal antigen response) causing cytokine storm
- The Eagle Effect: At high bacterial loads, GAS enters stationary phase and stops dividing. Beta-lactams (which work on dividing bacteria) become less effective. Clindamycin works by inhibiting protein synthesis (including toxin production) regardless of growth phase.
- Clostridium perfringens produces alpha-toxin (lecithinase)
- Alpha-toxin lyses cell membranes, causing massive tissue necrosis
- Rapid gas production (CO2, H2) causes crepitus
- Extremely rapid progression - can be fatal within hours
- Gram-negative rod found in warm seawater
- Enters through minor wounds during seafood handling or swimming
- Produces cytolysins and proteases
- Particularly severe in patients with liver disease or haemochromatosis (iron overload feeds bacterial growth)
- Mortality 50-60% if septicemic
Necrosis can advance rapidly along fascial planes, so a deceptively small area of involvement at presentation may become extensive within hours if not debrided. Delay to operative debridement is the strongest modifiable determinant of death: in McHenry's series the mean time from admission to surgery was 90 hours in non-survivors versus 25 hours in survivors. The infection cannot be controlled with antibiotics alone.
The risk-factor lists name NSAIDs and varicella, but the reason they matter is a recurring viva discussion point that is worth holding clearly:
- NSAIDs mask the diagnosis. By blunting fever, pain and the inflammatory response, NSAIDs can make early necrotizing fasciitis look like a settling cellulitis - delaying recognition and surgery (the one modifiable mortality driver). A child or young adult on regular NSAIDs whose "cellulitis" is not improving deserves heightened, not lowered, suspicion.
- The proposed biological harm (controversial). Beyond masking, NSAIDs have been hypothesised to worsen invasive group A streptococcal disease - by impairing neutrophil function and possibly up-regulating cytokine/superantigen responses. The evidence is observational and confounded (sicker children get more analgesia), so causation is unproven, but the association is strong enough that avoiding NSAIDs in suspected invasive GAS infection is widely advised.
- Varicella in children is the classic precipitant for paediatric Type II (GAS) necrotizing fasciitis - the chickenpox lesions are the skin breach. A febrile, disproportionately painful, rapidly worsening lesion in a child with varicella is necrotizing fasciitis until proven otherwise.
Exam point: in a child with varicella or a patient on NSAIDs, the drug/illness both predisposes to and masks necrotizing fasciitis - lower your threshold for surgical exploration, and avoid NSAIDs when invasive GAS is suspected.
Clinical Presentation
The Clinical Challenge: Early necrotizing fasciitis mimics cellulitis. The key is recognizing the discordance between patient symptoms (severe) and examination findings (relatively minor).
History
-
Pain out of proportion - THE cardinal feature
- Severe pain that seems excessive for appearance
- Pain extending beyond area of visible erythema
- Inadequate response to analgesia
- May paradoxically improve as nerves undergo necrosis (ominous sign)
-
Rapid progression
- "It wasn't like this 4 hours ago"
- Erythema spreading despite antibiotics
- Blisters appearing over hours
-
Systemic symptoms
- Fever, rigors, sweating
- Nausea, vomiting, diarrhea
- Confusion, altered consciousness
- "Feeling like I'm going to die"
- Minor trauma (scratch, insect bite, abrasion)
- Recent surgery (abdominal, perineal, orthopaedic)
- Injection (IVDU, intramuscular injection)
- Perianal abscess, pilonidal disease
- Childbirth, episiotomy
- Varicella infection (children)
- NSAID use (may mask early symptoms, promotes bacterial invasion)
Physical Examination
Hard Signs (100% Specific - Immediate Surgery)
Any ONE of these mandates immediate surgery:
-
Crepitus
- Gas in tissues (palpable crackling)
- Best felt at periphery of infection
- May not be present in Type II (GAS)
-
Skin Necrosis
- Dusky, purplish discoloration
- Non-blanching erythema
- Loss of sensation (cutaneous nerve necrosis)
-
Bullae
- Hemorrhagic (blood-filled): More ominous
- Serous (clear fluid): Still concerning
- Indicate dermal-epidermal separation from vascular thrombosis
-
Dishwater Discharge
- Gray, thin, foul-smelling discharge
- "Dishwater" or "washing-up water" appearance
- May see on spontaneous skin breakdown or aspiration
-
Fascial Necrosis Visible
- Frank tissue necrosis visible through skin breaks
- Gray, non-viable fascia
Examiner: "A patient with diabetes presents with leg pain and redness. How do you differentiate necrotizing fasciitis from cellulitis?"
Answer: "I would be concerned about necrotizing fasciitis if there is:
- Pain out of proportion to examination findings
- Systemic toxicity - fever, tachycardia, hypotension, confusion
- Failure to respond to 24-48 hours of IV antibiotics
- Hard signs - crepitus, bullae, skin necrosis, woody induration
If I have clinical concern, I would perform the finger test - bedside incision under local anaesthetic. Lack of bleeding, 'dishwater' pus, and fascial necrosis that separates easily confirms the diagnosis and mandates immediate extensive debridement."
Differential Diagnosis
- Distinguishing features
- Erythema, warmth, well/ill-defined margin; systemically less unwell; responds to antibiotics
- Key discriminator from NF
- Pain proportionate to signs; no crepitus, bullae or dishwater pus; improves on antibiotics
- Distinguishing features
- Localised fluctuant collection; point tenderness
- Key discriminator from NF
- Drains pus, not dishwater fluid; no spreading fascial necrosis
- Distinguishing features
- Severe pain, crepitus, bronze skin, marked toxaemia
- Key discriminator from NF
- Primarily muscle (not fascia) necrosis - overlaps with Type III NF; same emergency management
- Distinguishing features
- Deep muscle abscess, often tropical; fever, localised muscle pain
- Key discriminator from NF
- Muscle-centred on imaging; lacks fascial 'dishwater' separation
- Distinguishing features
- Pain on passive stretch, tense compartment, post-injury/ischaemia
- Key discriminator from NF
- No systemic sepsis or skin necrosis; normal inflammatory markers
- Distinguishing features
- Unilateral swelling, calf tenderness; afebrile
- Key discriminator from NF
- No toxaemia, crepitus or skin necrosis; confirmed on Doppler
- Distinguishing features
- Hot swollen joint, monoarticular, raised urate/crystals
- Key discriminator from NF
- Joint-centred; no fascial necrosis; rapid response to anti-inflammatories
Perineal/genital necrotizing fasciitis (Fournier's gangrene) is listed above as a site, but it is examined as a distinct entity with its own scoring and source-control rules:
- Severity scoring: the Fournier's Gangrene Severity Index (FGSI) uses derangement of physiological variables (temperature, heart rate, respiratory rate, sodium, potassium, creatinine, bicarbonate, haematocrit, white cell count) to predict mortality - a higher score (commonly quoted threshold around 9) carries markedly worse survival. It is a prognostic adjunct, not a reason to delay surgery.
- Find and control the source: most cases are colorectal, urogenital, or cutaneous in origin. Source control may require a diverting colostomy (for a perianal/colorectal source or heavy faecal soiling of the wound) and a suprapubic catheter (for a urethral source) in addition to perineal debridement.
- The testes are usually spared: the testicular blood supply (gonadal vessels) is separate from the compromised perineal/scrotal fascial circulation, so the testes typically survive even after radical scrotal debridement - orchidectomy is rarely needed, and exposed testes can be temporarily housed in thigh pockets pending reconstruction.
- Multidisciplinary: urology, colorectal/general surgery and plastics are usually all involved; reconstruction (scrotal grafts, gracilis flaps) follows infection control.
Exam point: for Fournier's, say FGSI for prognosis, hunt and divert the colorectal/urogenital source (colostomy/suprapubic catheter), spare the testes (separate blood supply), and reconstruct only once the sepsis is controlled - the debride-early principle is identical to limb necrotizing fasciitis.
Investigations
Key Principle: Investigations should NOT delay surgery if clinical suspicion is high. The operating theatre is both diagnostic and therapeutic.
Laboratory Investigations
LRINEC Score (Laboratory Risk Indicator for NECrotizing fasciitis):
- Range
- Less than 150
- Points
- 0
- Range
- ≥150
- Points
- +4
- Range
- Less than 15
- Points
- 0
- Range
- 15-25
- Points
- +1
- Range
- Greater than 25
- Points
- +2
- Range
- Greater than 135
- Points
- 0
- Range
- 110-135
- Points
- +1
- Range
- Less than 110
- Points
- +2
- Range
- ≥135
- Points
- 0
- Range
- Less than 135
- Points
- +2
- Range
- ≤141
- Points
- 0
- Range
- Greater than 141
- Points
- +2
- Range
- ≤10
- Points
- 0
- Range
- Greater than 10
- Points
- +1
LRINEC Score Interpretation:
- Score less than 6: Low risk (PPV less than 50%)
- Score 6-7: Intermediate risk - high clinical vigilance
- Score ≥8: High risk (PPV 75%+) - strongly consider surgery
CRITICAL LIMITATION: LRINEC was developed retrospectively. A normal LRINEC does NOT exclude NF. Sensitivity is only 60-80%. Clinical judgement remains paramount. [4]
Other Laboratory Tests:
- Blood cultures: Positive in 20-50%, identifies causative organism
- Lactate: Elevated lactate indicates tissue hypoperfusion and worse prognosis
- Creatine kinase (CK): Elevated if myonecrosis (worse prognosis)
- Procalcitonin: May help differentiate bacterial infection from other causes
- Coagulation: PT/INR, APTT, fibrinogen, D-dimer (DIC is common)
- Arterial blood gas: Metabolic acidosis indicates severe sepsis
Imaging
Plain Radiograph (X-ray)
Role: Quick screening, may show gas in soft tissues
Findings:
- Gas tracking along fascial planes (pathognomonic but only present in 25-50%)
- More common in Type I (polymicrobial) and Type III (clostridial)
- May be absent in Type II (GAS)
Limitation: Low sensitivity; absence of gas does NOT exclude NF
The Finger Test (Bedside Diagnosis)
Indications: High clinical suspicion for NF but diagnosis uncertain
Technique:
- Perform under local anaesthesia at bedside or in theatre
- Make 2cm incision through skin and subcutaneous tissue down to fascia
- Observe for:
- Lack of bleeding (vessel thrombosis)
- "Dishwater" gray pus (pathognomonic)
- Necrotic fascia - gray, stringy, easily separates with finger dissection
- "Finger test" positive - can easily pass finger along fascial plane with no resistance
If positive: Proceed immediately to extensive debridement
DO NOT let imaging delay surgery. A patient with hard signs of NF should go directly to theatre. CT or MRI may be normal early in disease. The operating theatre is the definitive diagnostic tool - if fascia is necrotic and separates easily, the diagnosis is confirmed.
Management Principles
The Three Pillars of NF Management:
- Resuscitation - Aggressive fluid, vasopressor support, ICU admission
- Debridement - Early, extensive, repeated
- Antibiotics - Empiric broad-spectrum, include clindamycin for toxin inhibition
Initial Resuscitation
- Apply qSOFA/SOFA criteria
- Most NF patients meet sepsis criteria
- Many have septic shock requiring vasopressors
- Large bore IV access (ideally 2x large bore)
- Crystalloid bolus 30 mL/kg in first 3 hours
- Titrate to MAP greater than 65 mmHg, UO greater than 0.5 mL/kg/hr
- Central venous access for monitoring and vasopressors
- Noradrenaline first-line if hypotensive despite fluids
- Target MAP greater than 65 mmHg
- May need multiple agents
- All NF patients require ICU/HDU admission
- For ongoing resuscitation, monitoring, and repeated surgeries
- May need renal replacement therapy, mechanical ventilation
- DIC is common with GAS (Type II)
- Transfuse blood products as needed
- FFP, platelets, cryoprecipitate for active bleeding
Surgical Debridement
The Definitive Treatment: Surgery is both diagnostic and therapeutic. No amount of antibiotics can substitute for adequate debridement of necrotic tissue.
Surgical Debridement Technique
- Operate as soon as the patient is resuscitated enough for anaesthesia (within hours, not days)
- Delay to debridement is the strongest modifiable predictor of death (90h vs 25h, McHenry); delay beyond 12h markedly increases debridements, septic shock and AKI (Kobayashi)
- Do not delay for imaging if clinical diagnosis clear
- Aggressive, extensive debridement
- All necrotic tissue must be removed
- Healthy tissue bleeds - debride until you see bleeding edges
- Fasciotomies if compartment syndrome suspected
-
Incision
- Longitudinal incision over area of maximal involvement
- Extend beyond visible erythema to healthy tissue
-
Assess Fascia (Finger Test)
- Necrotic fascia is gray, stringy
- Easily separates from underlying muscle with finger dissection
- Healthy fascia is glistening white and adherent
-
Debride Fascia
- Excise all necrotic fascia with no resistance
- Continue until fascia bleeds and is adherent
- May need to extend incisions to follow necrosis
-
Assess Muscle
- Healthy muscle: Pink, contracts to stimulation, bleeds when cut
- Necrotic muscle: Dull, non-contractile, does not bleed
- Debride non-viable muscle (myonecrosis = worse prognosis)
-
Assess Skin
- Initially viable skin may become necrotic over 24-48 hours
- Preserve skin if viable (can excise at relook)
- Excise overtly necrotic skin
-
Wound Management
- Leave wounds open
- Apply saline-soaked dressings or NPWT
- Plan for return to theatre
Key Points for Viva:
- "When in doubt, cut it out" - if clinical suspicion, explore surgically
- Debride until it bleeds - necrotic tissue does not bleed
- Healthy fascia is adherent - necrotic fascia separates easily
- Plan for re-look - most patients need 2-4 debridements
- Life over limb - do not delay amputation if indicated
Complications and Prognosis
Complications
- Septic shock - multi-organ failure, DIC, death
- ARDS - acute respiratory distress syndrome
- Acute kidney injury - from sepsis, rhabdomyolysis
- Limb loss - amputation required in 15-20%
- Exsanguinating hemorrhage - from eroded vessels
- Toxic shock syndrome - especially Type II (GAS)
- Chronic wounds - prolonged healing, skin grafts
- Scarring and contractures - may limit function
- Chronic pain - phantom limb pain if amputated
- Psychological morbidity - PTSD, depression, body image issues
- Functional impairment - particularly after limb amputation
Prognostic Factors
Factors Associated with Increased Mortality:
- Relative Risk
- Strongest modifiable risk
- Comments
- Non-survivors waited ~90h vs ~25h (McHenry); delay beyond 12h increases debridements/shock/AKI (Kobayashi)
- Relative Risk
- 2x mortality
- Comments
- Recognition and surgical referral delays
- Relative Risk
- 2-3x mortality
- Comments
- Reduced physiological reserve
- Relative Risk
- 1.5-2x mortality
- Comments
- Immunocompromise, vascular disease
- Relative Risk
- 30-70% mortality
- Comments
- Cytokine storm, DIC
- Relative Risk
- Higher mortality
- Comments
- Harder to debride, vital structures
- Relative Risk
- Poor prognosis
- Comments
- Extremes of immune response
- Relative Risk
- 2x mortality
- Comments
- Marker of severe sepsis
- Relative Risk
- 2x mortality
- Comments
- Must debride to healthy tissue
Survival Outcomes
- Historical: 70-80% (pre-antibiotic era)
- Current: 20-40% with modern treatment
- Early recognition and aggressive surgery: 10-25%
- Delayed treatment: 50-70%
- Recognition within 24 hours of symptom onset
- Surgery within 6-8 hours of presentation
- Adequate debridement (multiple re-looks)
- ICU care with multi-organ support
- Clindamycin in antibiotic regimen
- IVIG in streptococcal toxic shock
Guidelines, Registries & Global Practice
Global Epidemiology
Necrotising fasciitis is uncommon but its incidence appears to be rising worldwide. Reported population incidence is approximately 0.4-1.0 per 100,000 per year in high-income countries, with overall mortality of 20-40% even in modern series. According to PubMed, the McHenry single-centre series reported 29% mortality and identified delay to debridement as the dominant determinant of death PMID 7748037, while the Stevens & Bryant NEJM review summarises the global microbiology and management of necrotising soft-tissue infections PMID 29211672.
- Predominant pattern
- Type I polymicrobial in diabetics/elderly; Type II GAS in healthy adults
- Notable organisms / risks
- Rising invasive GAS; MRSA in some regions
- Predominant pattern
- Marine-acquired NSTI
- Notable organisms / risks
- Vibrio vulnificus (warm seawater, liver disease); Aeromonas (freshwater)
- Predominant pattern
- Type I polymicrobial; high diabetes prevalence
- Notable organisms / risks
- Klebsiella, Vibrio, marine exposure
- Predominant pattern
- Late presentation, higher mortality
- Notable organisms / risks
- Delayed access to theatre/ICU is the key driver
Guideline Comparison
There is broad international consensus on the core principles - early surgical debridement, broad-spectrum antibiotics with clindamycin for toxin suppression, and aggressive resuscitation - although no high-quality randomised data exist for the surgical strategy itself.
- Position on diagnosis & timing
- Surgery is diagnostic and therapeutic; do not delay debridement for imaging; LRINEC supportive not exclusionary
- Antibiotic & adjunct guidance
- Broad-spectrum empirical cover + clindamycin; IVIG may be considered in STSS
- Position on diagnosis & timing
- Urgent surgical exploration when NSTI suspected; tissue Gram stain/culture
- Antibiotic & adjunct guidance
- Empirical broad-spectrum + clindamycin for GAS; narrow on culture
- Position on diagnosis & timing
- Recognise sepsis early, immediate senior surgical referral, no delay for imaging
- Antibiotic & adjunct guidance
- Local microbiology-guided broad-spectrum + clindamycin; sepsis-six resuscitation
- Position on diagnosis & timing
- High clinical suspicion mandates exploration; LRINEC adjunctive only
- Antibiotic & adjunct guidance
- Piperacillin-tazobactam or meropenem + clindamycin ± vancomycin; benzylpenicillin + clindamycin for confirmed GAS
Almost all guideline recommendations on the surgical management of NSTI are based on observational data and expert consensus (low-grade evidence) - there are no RCTs of debridement timing or strategy. The strongest comparative evidence in this field is the Fernando 2019 meta-analysis on diagnostic accuracy PMID 29672405 and the Darenberg 2003 RCT of IVIG in STSS PMID 12884156. No dedicated NF registry exists; epidemiology is drawn from national infection surveillance (e.g. invasive GAS programmes) and single-centre cohorts.
Access, Equity & Wound-Healing Considerations
Globally, determinants of NF outcome extend beyond the pathogen and the operating theatre:
- Rural and remote access: In many countries patients first present to facilities without on-site ICU or surgical capability and require urgent transfer to a definitive centre; transfer time is itself a contributor to debridement delay and mortality.
- Disadvantaged and Indigenous populations: Worldwide, groups with higher rates of diabetes, chronic kidney disease and skin infection (including Indigenous populations) carry elevated NF risk; renal dosing of antibiotics, family involvement and culturally safe wound care should inform management.
- Smoking cessation: Smoking impairs graft take and wound healing, so supporting cessation (behavioural support plus nicotine replacement therapy) is important for reconstructive success in survivors.
Viva Practice Scenarios
Practise clinical reasoning and management decisions out loud
“A 55-year-old diabetic man presents with a painful, swollen right leg. He had a minor cut 3 days ago. He appears unwell with HR 120, BP 90/60, T 39.2°C. There is erythema from mid-calf to mid-thigh with woody induration. He has severe pain despite IV morphine. How would you manage this patient?”
“You are in theatre and have made an incision over the affected area. Describe what findings would confirm necrotizing fasciitis and your operative approach.”
“A previously healthy 35-year-old woman presents with rapidly progressive leg pain and redness 2 days after a minor skin abrasion. Her LRINEC score is 4. What are your concerns and how would you proceed?”
Classification
- Type I: Polymicrobial (aerobic + anaerobic), diabetics, post-surgical, Fournier's
- Type II: Monomicrobial (GAS, S. aureus), healthy adults, minor trauma
- Type III: Clostridial (gas gangrene), Vibrio vulnificus (seawater)
Clinical Features
- PAIN OUT OF PROPORTION - cardinal early sign
- Hard signs: Crepitus, necrosis, bullae, dishwater pus - immediate surgery
- Soft signs: Disproportionate pain, rapid spread, systemic toxicity, antibiotic failure
- Woody induration - tense swelling beyond erythema
LRINEC Score
- CRP greater than 150 (+4), WCC greater than 25 (+2), Hb less than 110 (+2)
- Na less than 135 (+2), Creatinine greater than 141 (+2), Glucose greater than 10 (+1)
- Score ≥6 intermediate risk, ≥8 high risk
- CRITICAL: Sensitivity only 60-80% - clinical judgement trumps score
Finger Test
- Bedside incision to fascia under local anaesthetic
- Lack of bleeding indicates vessel thrombosis
- Dishwater gray pus is pathognomonic
- Necrotic fascia separates easily with finger dissection
- If positive - proceed to extensive debridement
Antibiotics
- Empiric: Piperacillin-tazobactam + Clindamycin + Vancomycin
- GAS: Benzylpenicillin 2.4g IV q4h + Clindamycin 900mg IV q8h
- ALWAYS include clindamycin - inhibits toxin production (Eagle effect)
- Vibrio: Doxycycline + Ceftriaxone
Surgical Principles
- Time is tissue - delay to debridement drives mortality (90h vs 25h, McHenry)
- Debride until it bleeds - necrotic tissue does not bleed
- Healthy fascia is adherent - necrotic fascia separates easily
- Plan re-look at 24-48 hours - most need 2-4 debridements
- Life over limb - amputate if refractory sepsis
Prognosis
- Overall mortality 20-40%, up to 70% if delayed
- Delay to debridement is the strongest modifiable mortality driver
- GAS toxic shock - 30-70% mortality
- Amputation required in 15-20%
Key Exam Phrases
- Pain out of proportion = NF until proven otherwise
- When in doubt, cut it out
- The operating theatre is both diagnostic and therapeutic
- Surgery should not be delayed for imaging
- Clindamycin inhibits toxin production regardless of bacterial growth phase
Evidence Base
LRINEC Score Development
- Retrospective derivation/validation (145 NF vs 309 severe cellulitis/abscess)
- Six routine variables: CRP, WCC, Hb, sodium, creatinine, glucose
- Cut-off of 6 gave PPV 92.0% and NPV 96.0% in this cohort
- AUC 0.98 (developmental) and 0.976 (validation)
LRINEC, Exam & Imaging Accuracy (Meta-analysis)
- Systematic review/meta-analysis: 23 studies, n=5982
- LRINEC ≥6 pooled sensitivity only 68.2%, specificity 84.8%
- LRINEC ≥8 sensitivity 40.8%, specificity 94.9%
- CT sensitivity 88.5%/specificity 93.3%; plain film sensitivity 48.9%
A LRINEC of Zero Does Not Exclude NF
- Case report of a 37-year-old man with surgically confirmed NF
- LRINEC score was 0 despite established disease
- Illustrates the danger of using LRINEC to rule out NF
- Reinforces that NF remains a clinical diagnosis
Time to Surgery and Outcome
- 65 patients with necrotising soft-tissue infection
- Mean time admission-to-operation 90 h in non-survivors vs 25 h in survivors (p=0.0002)
- Average 3.3 debridements per patient; overall mortality 29%
- Early debridement was the key modifiable determinant of survival
Delay Increases Debridements & Morbidity
- Retrospective cohort of 47 NSTI patients (overall mortality 17%)
- Surgery delayed beyond 12 h required far more debridements (7.4 vs 2.3, p<0.001)
- Delay beyond 12 h associated with more septic shock and acute kidney injury
- Effect persisted after adjustment for confounders
Clindamycin Suppresses Streptococcal Toxins
- In vitro study of 14 fully susceptible S. pyogenes isolates
- Clindamycin superior to penicillin at reducing SPE-A and SPE-B production
- Effect independent of bacterial growth phase (rationale for the Eagle effect)
- Supports adding clindamycin even to penicillin-susceptible GAS
IVIG in Streptococcal Toxic Shock (RCT)
- European randomised, double-blind, placebo-controlled trial in STSS
- Terminated early for slow recruitment (21 patients enrolled)
- 28-day mortality 3.6-fold higher in placebo group (not statistically significant)
- Significant improvement in SOFA score and superantigen neutralisation with IVIG
For the exam, remember:
- LRINEC score has only 68% sensitivity - clinical judgement essential
- Delay to debridement is the key modifiable mortality driver (90h vs 25h, McHenry)
- Clindamycin inhibits toxin production - always include
- IVIG in STSS has one underpowered RCT (Darenberg) - supportive but not definitive
- Hyperbaric oxygen evidence is weak - should not delay surgery
References
-
Sartelli M, Guirao X, Hardcastle TC, et al. 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J Emerg Surg. 2018;13:58. doi:10.1186/s13017-018-0219-9
-
Stevens DL, Bryant AE. Necrotizing Soft-Tissue Infections. N Engl J Med. 2017;377(23):2253-2265. doi:10.1056/NEJMra1600673
-
Arif N, Yousfi S, Vinnard C. Deaths from necrotizing fasciitis in the United States, 2003-2013. Epidemiol Infect. 2016;144(6):1338-1344. doi:10.1017/S0950268815002745
-
Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535-1541. doi:10.1097/01.ccm.0000129486.35458.7d
-
Fernando SM, Tran A, Cheng W, et al. Necrotizing Soft Tissue Infection: Diagnostic Accuracy of Physical Examination, Imaging, and LRINEC Score: A Systematic Review and Meta-Analysis. Ann Surg. 2019;269(1):58-65. doi:10.1097/SLA.0000000000002774
-
Wilson MP, Schneir AB. A case of necrotizing fasciitis with a LRINEC score of zero: clinical suspicion should trump scoring systems. J Emerg Med. 2013;44(5):928-931. doi:10.1016/j.jemermed.2012.09.039
-
McHenry CR, Piotrowski JJ, Petrinic D, Malangoni MA. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg. 1995;221(5):558-565. doi:10.1097/00000658-199505000-00013
-
Kobayashi L, Konstantinidis A, Shackelford S, et al. Necrotizing soft tissue infections: delayed surgical treatment is associated with increased number of surgical debridements and morbidity. J Trauma. 2011;71(5):1400-1405. doi:10.1097/TA.0b013e31820db8fd
-
Mascini EM, Jansze M, Schouls LM, Verhoef J, Van Dijk H. Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci. Int J Antimicrob Agents. 2001;18(4):395-398. doi:10.1016/s0924-8579(01)00413-7
-
Darenberg J, Ihendyane N, Sjölin J, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003;37(3):333-340. doi:10.1086/376630
-
Therapeutic Guidelines Limited. Therapeutic Guidelines: Antibiotic. Melbourne: Therapeutic Guidelines Limited.